Poseida Therapeutics, Inc.
VCAR COMPOSITIONS AND METHODS FOR USE
Last updated:
Abstract:
Disclosed are VHH chimeric antigen receptors (VCARs), VCAR transposons encoding VCARs of the disclosure, cells modified to express VCARs of the disclosure, as well as methods of making and methods of using the same for adoptive cell therapy.
Status:
Application
Type:
Utility
Filling date:
20 Dec 2018
Issue date:
13 May 2021